409 related articles for article (PubMed ID: 21537080)
1. Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload.
Koitabashi N; Danner T; Zaiman AL; Pinto YM; Rowell J; Mankowski J; Zhang D; Nakamura T; Takimoto E; Kass DA
J Clin Invest; 2011 Jun; 121(6):2301-12. PubMed ID: 21537080
[TBL] [Abstract][Full Text] [Related]
2. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
[TBL] [Abstract][Full Text] [Related]
3. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
4. TGF-β-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells.
Yumoto K; Thomas PS; Lane J; Matsuzaki K; Inagaki M; Ninomiya-Tsuji J; Scott GJ; Ray MK; Ishii M; Maxson R; Mishina Y; Kaartinen V
J Biol Chem; 2013 May; 288(19):13467-80. PubMed ID: 23546880
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
[TBL] [Abstract][Full Text] [Related]
6. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
[TBL] [Abstract][Full Text] [Related]
7. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.
Zhang CL; Zhao Q; Liang H; Qiao X; Wang JY; Wu D; Wu LL; Li L
J Mol Cell Cardiol; 2018 Mar; 116():135-144. PubMed ID: 29438665
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice.
Yang L; Roh YS; Song J; Zhang B; Liu C; Loomba R; Seki E
Hepatology; 2014 Feb; 59(2):483-95. PubMed ID: 23996730
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta promotes Th17 cell development through inhibition of SOCS3.
Qin H; Wang L; Feng T; Elson CO; Niyongere SA; Lee SJ; Reynolds SL; Weaver CT; Roarty K; Serra R; Benveniste EN; Cong Y
J Immunol; 2009 Jul; 183(1):97-105. PubMed ID: 19535626
[TBL] [Abstract][Full Text] [Related]
10. Sialyltransferase7A promotes angiotensin II-induced cardiomyocyte hypertrophy via HIF-1α-TAK1 signalling pathway.
Yan X; Zhao R; Feng X; Mu J; Li Y; Chen Y; Li C; Yao Q; Cai L; Jin L; Han C; Zhang D
Cardiovasc Res; 2020 Jan; 116(1):114-126. PubMed ID: 30854566
[TBL] [Abstract][Full Text] [Related]
11. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor.
Sakata Y; Chancey AL; Divakaran VG; Sekiguchi K; Sivasubramanian N; Mann DL
Basic Res Cardiol; 2008 Jan; 103(1):60-8. PubMed ID: 18034274
[TBL] [Abstract][Full Text] [Related]
13. Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1/p38 signaling in mice.
Wu L; Mei L; Chong L; Huang Y; Li Y; Chu M; Yang X
Life Sci; 2016 Jan; 145():121-6. PubMed ID: 26706286
[TBL] [Abstract][Full Text] [Related]
14. Transforming Growth Factor β1 (TGF-β1) Activates Hepcidin mRNA Expression in Hepatocytes.
Chen S; Feng T; Vujić Spasić M; Altamura S; Breitkopf-Heinlein K; Altenöder J; Weiss TS; Dooley S; Muckenthaler MU
J Biol Chem; 2016 Jun; 291(25):13160-74. PubMed ID: 27129231
[TBL] [Abstract][Full Text] [Related]
15. A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
Watkins SJ; Jonker L; Arthur HM
Cardiovasc Res; 2006 Feb; 69(2):432-9. PubMed ID: 16360132
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction.
Ikeuchi M; Tsutsui H; Shiomi T; Matsusaka H; Matsushima S; Wen J; Kubota T; Takeshita A
Cardiovasc Res; 2004 Dec; 64(3):526-35. PubMed ID: 15537506
[TBL] [Abstract][Full Text] [Related]
17. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
[TBL] [Abstract][Full Text] [Related]
18. Activation of SIRT1 by Resveratrol Alleviates Pressure Overload-Induced Cardiac Hypertrophy via Suppression of TGF-β1 Signaling.
Chen Y; He T; Zhang Z; Zhang J
Pharmacology; 2021; 106(11-12):667-681. PubMed ID: 34518478
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway.
Zhang Y; Shao L; Ma A; Guan G; Wang J; Wang Y; Tian G
Hypertens Res; 2014 Jan; 37(1):43-9. PubMed ID: 24089264
[TBL] [Abstract][Full Text] [Related]
20. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
Ma SQ; Guo Z; Liu FY; Hasan SG; Yang D; Tang N; An P; Wang MY; Wu HM; Yang Z; Fan D; Tang QZ
Acta Pharmacol Sin; 2021 Oct; 42(10):1575-1586. PubMed ID: 33462378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
